COMPARISON OF CISPLATIN AND MITOMYCIN/5-FU AS RADIOSENSITIZERS IN THE TREATMENT OF VULVAR CANCER - RESULTS OF A SINGLE INSTITUTIONAL COHORT STUDY

被引：0
|
作者：
Linz, V. [1 ]
Schwanbeck, C. [2 ]
Anic, K. [1 ]
Jaekel, J. [3 ]
Schmidt, M. W. [1 ]
Krajnak, S. [1 ]
Schwab, R. [1 ]
Weikel, W. [1 ]
Seeger, A. [1 ]
Schmidt, M. [1 ]
Schmidberger, H. [2 ]
Hasenburg, A. [1 ]
Battista, M. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynaecol, Univ Med Ctr, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Radiooncol & Radiotherapy, Univ Med Ctr, Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Radiooncol & Radiotherapy, Dept Pathol, Mainz, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
345
引用
收藏
页码：A350 / A350
页数：1
相关论文
共 50 条
  • [1] Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study
    Valerie Catherine Linz
    Carina Schwanbeck
    Slavomir Krajnak
    Katharina Anic
    Jörg Jäkel
    Roxana Schwab
    Marcus Schmidt
    Heinz Schmidberger
    Annette Hasenburg
    Marco Johannes Battista
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1391 - 1399
  • [2] Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study
    Linz, Valerie Catherine
    Schwanbeck, Carina
    Krajnak, Slavomir
    Anic, Katharina
    Jaekel, Joerg
    Schwab, Roxana
    Schmidt, Marcus
    Schmidberger, Heinz
    Hasenburg, Annette
    Battista, Marco Johannes
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) : 1391 - 1399
  • [3] Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer
    Yu, Irene S.
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] No improvement of treatment results of concurrent radiochemotherapy of cervical cancer with 5-FU compared to cisplatin
    Fietkau, R
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (06) : 356 - 357
  • [6] An assessment of the results of the palliative treatment of gastric carcinoma with cisplatin and 5-FU
    Zbrzezniak, J
    Jagiello-Gruszfeld, AI
    Czerniawska, M
    Szablowska-Siwik, S
    Sikorska, M
    Wachula, E
    Ziomek, M
    Godlewski, J
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324
  • [7] RANDOMIZED COMPARISON OF 5-FU ALONE OR COMBINED WITH MITOMYCIN AND CYTARABINE (MFC) IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    COCCONI, G
    DELISI, V
    DIBLASIO, B
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1263 - 1266
  • [8] Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer
    Klein, B
    Sadikov, E
    Mishaeli, M
    Levin, I
    Figer, A
    [J]. ONCOLOGY REPORTS, 2000, 7 (04) : 875 - 877
  • [9] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    [J]. CANCER, 1972, 29 (05) : 1308 - +
  • [10] A study of epirubicin, cisplatin and prolonged infusional 5-FU (ECF) treatment for relapsed epithelial ovarian cancer
    Blagden, SP
    Earl, HM
    Brenton, J
    Murray, N
    Shaw, CJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 107 - 107
12345